Skip to content
OpenCapital
Get started

Dogwood Therapeutics DWTX Q1 2025 Annual earnings

Reported May 8, 2025 · Before market open

Diluted EPS-$4.21Miss by $3.44
EPS estimate-$0.77

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.13

Financials

Q1 2025

Income statement

See full
Operating income-$4.4M-237%
Net income-$10.9M-746%
EPS (diluted)-$8.45-403%

Balance sheet

See full
Cash & equivalents$17.5M+637%
Total debt$191.2K—
Total equity$7.1M+167%
Total assets$97.0M+2,908%

Cash flow

See full
Operating cash flow-$4.7M-400%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$124.12M—
Enterprise value$106.78M—

Returns & leverage

See full
Return on equity-451.3%-697pp
Debt / equity0×—
Current ratio7.4×+1.8×

Versus estimates

Diluted EPS

Q1 2026-$0.15Beat by $0.07Q4 2025-$0.26Beat by $0.60Q3 2025-$8.20Miss by $6.97Q2 2025-$1.99Miss by $0.73
Q1 2025-$4.21Miss by $3.44
Q4 2024-$5.90Miss by $4.54

Ask the moment Dogwood Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dogwood Therapeutics report Q1 2025 earnings?
Dogwood Therapeutics (DWTX) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Dogwood Therapeutics's Q1 2025 revenue and EPS?
Dogwood Therapeutics reported diluted EPS of $-4.21 for Q1 2025.
Did Dogwood Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.77 by $3.44.
How did Dogwood Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 5914.3% from $-0.07.
Where can I find Dogwood Therapeutics's Q1 2025 SEC filings?
You can read the 10-K periodic report (0001558370-25-004167) directly on SEC EDGAR. The filing index links above go to sec.gov.